Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs (Q45888388)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

0 references

author name string

Bin Wang

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Thomas M O'Malley

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Lingfei Xu

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Charles Vite

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Ping Wang

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Patricia A O'Donnell

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

N Matthew Ellinwood

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Mark E Haskins

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Katherine Parker Ponder

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

publication date

7 November 2005

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

87

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

8-21

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

Incidence of the mucopolysaccharidoses in Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Murine mucopolysaccharidosis VIL: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Enzyme replacement and enhancement therapies for lysosomal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Gene therapy progress and prospects: gene therapy of lysosomal storage disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Long-term normalization in the central nervous system, ocular manifestations, and skeletal deformities by a single systemic adenovirus injection into neonatal mice with mucopolysaccharidosis VII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Gene transfer of low levels of beta-glucuronidase corrects hepatic lysosomal storage in a large animal model of mucopolysaccharidosis VII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.08.014

7 January 2021

Identifiers

10.1016/J.YMGME.2005.08.014

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/16275036

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45888388&oldid=2088678618"